Validating Email ...

The #1 Authority on Penny Stocks for OVER 7 YEARS RUNNING

Top 9 Stock for July 23

Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) surged by 81.89% and closed at $21.70 on heavy volume of 19.18 million shares. The company announced that it has received an FDA approval for its generic version of Lovenox. (NASDAQ:MNTA), (MNTA)

Infinera Corp. (NASDAQ: INFN) soared by 30.76% and closed at $9.14 on heavy volume of 8.48 million shares. The surge came after the company reported its financial results for the Q2. (NASDAQ:INFN), (INFN)

OceanFreight Inc. (NASDAQ: OCNF) gained by 27.10% and closed at $1.22 with overall volume of 2.98 million shares. (NASDAQ:OCNF), (OCNF)

NxStage Medical Inc. (NASDAQ: NXTM) jumped up by 22.91% and closed at $17.06 on above-average volume of 1.52 million shares. The company announced that it has narrowed its Q2 loss to $8.3 million from year-ago loss of $12.5 million. (NASDAQ:NXTM), (NXTM)

Genzyme Corp. (NASDAQ: GENZ) soared by 15.41% and closed at $62.52, on heavy volume of 20.85 million shares, amid acquisition speculation. (NASDAQ:GENZ), (GENZ)

Seacor Holdings Inc. (NYSE: CKH) moved up by 14.16% and closed at $85.09 on above-average volume of 644.1K shares. The company reported a 51% rise in its Q2 net income. (NYSE:CKH), (CKH)

Chipotle Mexican Grill Inc. (NYSE: CMG) gained by 9.27% and closed at $145.50 on heavy volume of 3.13 million shares, a day after the company reported its Q2 results. (NYSE:CMG), (CMG)

athenahealth Inc. (NASDAQ: ATHN) soared by 22.44% and closed at $27.01, on above-average volume of 3.13 million shares, after posting better than expected results for its Q2. (NASDAQ:ATHN), (ATHN)

NxStage Medical Inc. (NASDAQ: NXTM) rose by 22.91% and closed at $17.06, on strong volume of 1.52 million shares, after reporting a narrowed loss in its Q2. (NASDAQ:NXTM), (NXTM)

Beacon Equity Group Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

About BeaconEquity.com

BeaconEquity.com is committed to producing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Beacon Equity Group Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.